Search results
Results from the WOW.Com Content Network
For women, taking ashwagandha may help keep menstrual cycles regular, reduce symptoms associated with menopause and even improve sexual function. But the key word here is may. Daidone notes that ...
Estrogen dominance is widely discussed by many proponents and on many alternative medicine websites, including: Christiane Northrup , former obstetrics and gynecology physician, believes that estrogen dominance is linked to "allergies, autoimmune disorders, breast cancer, uterine cancer, infertility, ovarian cysts, and increased blood clotting ...
Signs of hyperestrogenism may include heightened levels of one or more of the estrogen sex hormones (usually estradiol and/or estrone), lowered levels of follicle-stimulating hormone and/or luteinizing hormone (due to suppression of the hypothalamic–pituitary–gonadal axis by estrogen), and lowered levels of androgens such as testosterone (generally only relevant to males). [1]
“Ashwagandha is a very gentle herb, but occasional side effects include stomach upset, nausea, or diarrhea,” says Lin. Pregnant women should avoid ashwagandha, says Lin, because it can ...
Today, Ashwagandha is commonly sold over-the-counter as an herbal supplement and marketed to help with sleep, stress, focus, athletic performance, and more, per the NIH National Center for ...
Estrogen insensitivity syndrome (EIS), or estrogen resistance, is a form of congenital estrogen deficiency or hypoestrogenism [2] which is caused by a defective estrogen receptor (ER) – specifically, the estrogen receptor alpha (ERα) – that results in an inability of estrogen to mediate its biological effects in the body. [3]
One study observed the relationship between sexual motivation in lesbian and bisexual women and period-related changes in circulating estrogen concentrations. [18] Lesbian women who were at the estrogen peak of their fertile cycle reported increased sexual motivation for sexual contact with women, whereas bisexual women reported only a slight ...
The study, which involved 106 peri- and postmenopausal women and was presented at the Endocrine Society’s annual meeting in May, indicates women should self-monitor their vasomotor symptoms and ...